Should We Treat Subclinical Hypothyroidism ?

Established indications for treatment of subclinical hypothyroidism, but general guidelines can be submitted. High titers of antibodies to the TSH height andantithyroid progress hypothyroidism increases the likelihood of greater magnitude and duration of self-evident and therefore, the potential benefit in the treatment oflevothyroxine is increased. The presence of mild symptoms of hypothyroidism may be related to the potential benefit of treatment artar.Hassas use the TSH test,TSH levels fall too much as long as we are not raising blood levels of thyroid hormone provides an assurance from the risk of harm to the patient, to bebalanced against the potential benefit that, under quite small of normal . Minimalelevations of TSH in patients with coronary artery disease and only a small risk ofexposure to levothyroxine therapy may be advised to follow the patient's TSH levelmore.

In short, the continuous increase in antithyroid antibody titers, especially if 10 μUper mL (10 mU per L), the above seems reasonable to treat patients with a highTSH level. Their TSH level is only 5 to 10 μU per mL (5 to 10 mU per L) even if theaddition into the high, fatigue, dry skin, constipation, muscle cramps, or other common symptoms of patients suffering from hypothyroidism probably treatablerange. An algorithm is presented in Figure 1 summarizes this approach.